NEUROTECH INTERNATIONAL LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.062 AUD | +8.77% |
|
-12.50% | -8.70% |
| Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
| Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
